Could a simple drug save newborn brains? major trial tests High-Dose erythropoietin
NCT ID NCT01732146
First seen Nov 20, 2025 · Last updated Jun 13, 2026 · Updated 35 times
Summary
This study tested whether a high dose of erythropoietin, a drug that helps produce red blood cells, could prevent long-term brain damage in full-term newborns who suffered oxygen deprivation at birth. All 120 babies in the study received standard cooling therapy, and half also received the drug. The goal was to see if the drug improved survival without lasting neurological problems like motor, visual, or hearing impairments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOXIC-ISCHEMIC ENCEPHALOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cochin Hospital
Paris, 75014, France
Conditions
Explore the condition pages connected to this study.